Stay updated on Periop Chemo & Pembrolizumab in Gastric Cancer Clinical Trial
Sign up to get notified when there's something new on the Periop Chemo & Pembrolizumab in Gastric Cancer Clinical Trial page.

Latest updates to the Periop Chemo & Pembrolizumab in Gastric Cancer Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe footer revision tag was updated from v3.5.2 to v3.5.3. This indicates a minor site revision and does not alter the study details or eligibility information on the page.SummaryDifference0.1%

- Check21 days agoNo Change Detected
- Check29 days agoChange DetectedRevision tag updated from v3.5.0 to v3.5.2. The page now shows Revision: v3.5.2 and no longer lists v3.5.0.SummaryDifference0.1%

- Check43 days agoChange DetectedA new Results section has been added, detailing primary and secondary outcomes (pCR, OS, DFS, ORR) and time frames, along with the dates of results submission.SummaryDifference0.1%

- Check50 days agoChange DetectedRevision: v3.5.0 added and v3.4.3 removed, updating the page's revision metadata to v3.5.0.SummaryDifference0.1%

- Check57 days agoChange DetectedThe page was redesigned with a new layout and navigation; substantive study data such as eligibility, outcomes, and enrollment appear unchanged.SummaryDifference0.1%

- Check65 days agoChange DetectedRevision: v3.4.3 updated from v3.4.2.SummaryDifference0.1%

Stay in the know with updates to Periop Chemo & Pembrolizumab in Gastric Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Periop Chemo & Pembrolizumab in Gastric Cancer Clinical Trial page.